Live Breaking News & Updates on மருத்துவ புற்றுநோயியல் அலகு
Stay updated with breaking news from மருத்துவ புற்றுநோயியல் அலகு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antibiotic Link to Rise in Early Onset Colon Cancer? By Liam Davenport July 12, 2021 Exposure to antibiotics appears to be associated with the development of colon cancer, particularly in younger people, and could be contributing to the increase in early onset colorectal cancer (CRC) that is being documented, say UK researchers. The team conducted study using data from primary care in Scotland, which involved almost 8,000 cases of CRC and over 30,000 healthy controls. The analysis suggests that a history of antibiotic use among individuals younger that 50 appeared to increase the risk of developing colon cancer (but not rectal) by 49%. To our knowledge, this is the first study to link antibiotic use with the growing risk of early onset colon cancer, a disease which has been increasing at a rate of at least 3% per year over the last two decades, said study presenter Sarah Perrott, a medical student at the University of Aberdeen, Scotland, U.K. ....
Antibiotic Link to Rise in Early Onset Colon Cancer? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Provectus Biopharmaceuticals Announces Acceptance of PV-10® Immunotherapy Abstracts at American . Provectus Biopharmaceuticals Inc.April 28, 2021 GMT Intralesional (aka intratumoral) PV-10 administration for treatment of hepatic metastatic neuroendocrine tumors ( NCT0269367 ) Systemic administration of PV-10 for treatment of solid tumor cancers KNOXVILLE, TN, April 28, 2021 (GLOBE NEWSWIRE) Provectus (OTCQB: PVCT) today announced that two abstracts about data from clinical and preclinical study of investigational cancer immunotherapy PV-10 (rose bengal disodium) were accepted for the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, which will be held June 4-8 online. ....